Overall, these findings expand our knowledge of secondary metabolites in native Luzuriaga species and validate their bioactivity, especially their potential as a supplement in aid of Alzheimer’s disease (inhibition of the AChE enzyme), laying the groundwork for future studies. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.